Nicholas N. Vahanian

2018

In 2018, Nicholas N. Vahanian earned a total compensation of $1.4M as President at NewLink Genetics, a 53% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$180,915
Option Awards$712,173
Salary$495,002
Other$24,126
Total$1,412,216

Vahanian received $712.2K in option awards, accounting for 50% of the total pay in 2018.

Vahanian also received $180.9K in non-equity incentive plan, $495K in salary and $24.1K in other compensation.

Rankings

In 2018, Nicholas N. Vahanian's compensation ranked 7,460th out of 14,244 executives tracked by ExecPay. In other words, Vahanian earned more than 47.6% of executives.

ClassificationRankingPercentile
All
7,460
out of 14,244
48th
Division
Manufacturing
2,893
out of 5,765
50th
Major group
Chemicals And Allied Products
1,085
out of 2,128
49th
Industry group
Drugs
916
out of 1,817
50th
Industry
Pharmaceutical Preparations
719
out of 1,391
48th
Source: SEC filing on April 5, 2019.

Vahanian's colleagues

We found two more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2018.

2018

Charles Link

NewLink Genetics

Chief Executive & Scientific Officer

2018

Eugene Kennedy

NewLink Genetics

Chief Medical Officer

News

In-depth

You may also like